A Settlement has been reached in a lawsuit with the manufacturer of the weed-killer Imprelis®. The lawsuit claims that Imprelis® killed and damaged trees and other non-target vegetation.
Imprelis® was used by lawn care professionals on residential and commercial properties, as well as by golf courses, between August 31, 2010 and August 21, 2011. It was used in every state, except California and New York.
This Settlement will provide benefits to consumers and businesses with tree damage caused by Imprelis®.
To view Multimedia News Release, go to http://www.multivu.com/players/English/60753-imprelis-tree-damage-settlement
A small town lawyer is forced to fight a giant pharmaceutical company and the FDA to try to save his daughter’s life in Thompson’s edgy legal thriller. When his lawsuit uncovers fraud and corruption, he is confronted with an enemy who will resort to bribery, kidnapping and murder to win. Learn about the book and this author, www.larrydthompson.com Mystery Thriller
The American Civil Liberties Union today released a new video condemning the U.S. government practice of issuing death sentences without due process as part of its targeted killing policy. “Targeted Killing” is being released to coincide with the filing today of an unprecedented lawsuit by the ACLU and the Center for Constitutional Rights (CCR) challenging the government's asserted authority to use lethal force against U.S. citizens located far from any battlefield without judicial process, and without disclosing the standards it uses to target individuals for death.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/aclu/39479/
The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation.
A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
Purina today launched a new national campaign featuring the men and women who proudly make Beneful® Brand Dog Food, talking about why they feed it to their own dogs.
The commercial, captured at Purina’s Atlanta factory, highlights the care and accountability that goes into every bag of Beneful – and dispels misinformation about the quality and safety of one of Purina’s best brands in the wake of a baseless class action lawsuit. Purina associates, featured with their beloved pets, talk about their pride and confidence in the product that millions of dogs eat every day across America.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7544251-purina-pride-ad-campaign/
Vioxx Settlement
This is an important announcement for consumers about the prescription drug Vioxx. Vioxx was a drug commonly used to treat pain and inflammation in adults with arthritis.
A settlement was reached with the manufacturer of Vioxx and will provide refunds to anyone who paid for the medication. Consumers are eligible to get $50 or more. Personal injury claims related to this drug are not included in this settlement.
The deadline to file a claim is approaching – claims must be filed by May 6, 2014.
Details are available at http://www.VioxxSettlement.com or by calling 1-866-439-6932.
A Settlement has been reached in a bankruptcy involving claims about exposure to asbestos-containing gasket and packing products. Garlock Sealing Technologies LLC, The Anchor Packing Company, and Garrison Litigation Management Group, Ltd. (“Debtors”) have filed a plan of reorganization to restructure their business and pay claims.
The products (with names like Garlock, Blue-Gard, Gylon, and Flexseal) were used in places where steam, hot liquid or acids moved through pipes, including in shipbuilding, oil refinery, chemical, paper and pulp, semi-conductor, power, and construction industries as well as in maritime/naval vessels.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7476251-garlock-bankruptcy-asbestos/
The following is being released by the Notice Provider, Kinsella Media, LLC, about the lawsuit In re Automotive Parts Antitrust Litigation, MDL No. 2311.
There is an update for affected purchasers in this lawsuit about certain vehicle components, as there have been additional Settlements that may affect their rights.
Twelve additional Defendants have agreed to Settlements resolving claims that they fixed the price of certain vehicle components. (The Court previously approved settlements with 11 Defendants, totaling approximately $225 million.) The additional Settlements being presented for Court Approval total approximately $379 million.
The lawsuits allege that Defendants fixed the price of certain vehicle components, causing millions of consumers and businesses from around the country to pay more for certain new or leased vehicles and replacement parts. A complete list of included parts is available at the website, www.AutoPartsClass.com.
To view the multimedia release go to:
http://www.multivu.com/players/English/7982351-auto-parts-class-action-settlements/
The following statement is being issued by Block & Leviton LLP, Finkelstein Thompson LLP and Green & Noblin PC regarding the Drywall Antitrust Litigation.
If you purchased Wallboard INDIRECTLY from one or more of the companies listed below, your rights may be affected by proposed Settlements
Proposed class settlements totaling $10.5 million have been reached with two Defendants in In re Domestic Drywall Antitrust Litigation, MDL No. 2437 and 13-MD-2437, pending in the U.S. District Court for the Eastern District of Pennsylvania.
If you purchased for end use wallboard manufactured and/or distributed by CertainTeed Gypsum, Inc., USG Corporation, United States Gypsum Company, New NGC, Inc., Lafarge North America, Inc., Eagle Materials, Inc., American Gypsum Company LLC, PABCO Building Products, LLC, TIN, Inc., or their subsidiaries (collectively, the “Defendants”), between January 1, 2012 and November 30, 2014, you may be a class member. “Wallboard” means paper-backed gypsum wallboard, also called drywall or plasterboard.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7449651-drywall-class-action-settlement/
The following statement is being issued by Block & Leviton LLP, Finkelstein Thompson LLP and Green & Noblin PC regarding the Drywall Antitrust Litigation.
If you purchased Wallboard INDIRECTLY from one or more of the companies listed below, your rights may be affected by proposed Settlements
A proposed class settlement totaling $5.2 million has been reached with a defendant in In re Domestic Drywall Antitrust Litigation, MDL No. 2437 and 13-MD-2437, pending in the U.S. District Court for the Eastern District of Pennsylvania.
To view the multimedia release go to:
http://www.multivu.com/players/English/7975351-drywall-class-action-settlement/
The following statement is being issued by Jonathan Schochor, Chairman, Plaintiffs’ Steering Committee, regarding Jane Doe No. 1, et. al. v. Johns Hopkins Hospital, et al., No. 24-C-13-001041.
If you were a patient of, or treated by Johns Hopkins Hospital gynecologist, Dr. Nikita Levy, you are a member of a mandatory settlement class action.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65136-dr-nikita-levy-class-action-lawsuit-johns-hopkins-hospital-gynecology
